Name
bp1a_pm
Label
PM Systolic Blood Presure 1st Measurement
Units
millimeters of mercury
Type
numeric
Tags
Visit (Number) vs PM Systolic Blood Presure 1st Measurement
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,232 | 124.7 | ± 18.0 | 124.0 | -2.0 | 196.0 | 284 | 1,516 |
CPAP Titration Visit (CPAP) | 1,056 | 123.8 | ± 19.6 | 124.0 | -1.0 | 200.0 | 460 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 123.4 | ± 18.8 | 124.0 | -1.0 | 188.0 | 637 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 15.1 | ± 42.9 | -2.0 | -2.0 | 178.0 | 683 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 122.0 | ± 21.4 | 122.0 | -3.0 | 178.0 | 665 | 1,516 |
Gender vs PM Systolic Blood Presure 1st Measurement
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Systolic Blood Presure 1st Measurement
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Systolic Blood Presure 1st Measurement
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,232 | 124.7 | ± 18.0 | 124.0 | -2.0 | 196.0 | 284 | 1,516 |
Male | 788 | 125.7 | ± 17.1 | 126.0 | -1.0 | 196.0 | 170 | 958 |
Female | 444 | 123.0 | ± 19.4 | 122.0 | -2.0 | 174.0 | 114 | 558 |
Gender vs PM Systolic Blood Presure 1st Measurement
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,056 | 123.8 | ± 19.6 | 124.0 | -1.0 | 200.0 | 460 | 1,516 |
Male | 693 | 125.2 | ± 17.3 | 126.0 | -1.0 | 200.0 | 265 | 958 |
Female | 363 | 121.0 | ± 23.2 | 122.0 | -1.0 | 170.0 | 195 | 558 |
Gender vs PM Systolic Blood Presure 1st Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 123.4 | ± 18.8 | 124.0 | -1.0 | 188.0 | 637 | 1,516 |
Male | 572 | 123.8 | ± 19.5 | 124.0 | -1.0 | 188.0 | 386 | 958 |
Female | 307 | 122.6 | ± 17.5 | 124.0 | -1.0 | 162.0 | 251 | 558 |
Gender vs PM Systolic Blood Presure 1st Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 833 | 15.1 | ± 42.9 | -2.0 | -2.0 | 178.0 | 683 | 1,516 |
Male | 541 | 14.9 | ± 42.6 | -2.0 | -2.0 | 178.0 | 417 | 958 |
Female | 292 | 15.5 | ± 43.6 | -2.0 | -2.0 | 162.0 | 266 | 558 |
Gender vs PM Systolic Blood Presure 1st Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 851 | 122.0 | ± 21.4 | 122.0 | -3.0 | 178.0 | 665 | 1,516 |
Male | 552 | 123.2 | ± 19.3 | 124.0 | -2.0 | 178.0 | 406 | 958 |
Female | 299 | 119.8 | ± 24.6 | 121.0 | -3.0 | 170.0 | 259 | 558 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,232 | 124.7 | ± 18.0 | 124.0 | -2.0 | 196.0 | 284 | 1,516 |
Native American | 20 | 125.5 | ± 18.9 | 120.0 | 100.0 | 180.0 | 8 | 28 |
Asian | 74 | 122.0 | ± 13.9 | 121.0 | 82.0 | 158.0 | 15 | 89 |
Black | 120 | 125.0 | ± 20.8 | 124.5 | -1.0 | 174.0 | 52 | 172 |
Hispanic | 84 | 125.9 | ± 13.1 | 125.0 | 100.0 | 168.0 | 32 | 116 |
White | 926 | 124.9 | ± 17.8 | 124.0 | -2.0 | 196.0 | 176 | 1,102 |
Other | 8 | 113.6 | ± 49.4 | 120.0 | -1.0 | 164.0 | 1 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,056 | 123.8 | ± 19.6 | 124.0 | -1.0 | 200.0 | 460 | 1,516 |
Native American | 16 | 132.6 | ± 22.6 | 129.5 | 100.0 | 200.0 | 12 | 28 |
Asian | 58 | 122.2 | ± 11.2 | 120.0 | 102.0 | 150.0 | 31 | 89 |
Black | 96 | 125.3 | ± 23.3 | 125.5 | -1.0 | 180.0 | 76 | 172 |
Hispanic | 73 | 125.0 | ± 11.3 | 124.0 | 98.0 | 150.0 | 43 | 116 |
White | 808 | 123.3 | ± 20.1 | 125.0 | -1.0 | 180.0 | 294 | 1,102 |
Other | 5 | 130.8 | ± 22.3 | 126.0 | 108.0 | 168.0 | 4 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 123.4 | ± 18.8 | 124.0 | -1.0 | 188.0 | 637 | 1,516 |
Native American | 13 | 122.5 | ± 41.1 | 130.0 | -1.0 | 170.0 | 15 | 28 |
Asian | 49 | 121.1 | ± 10.9 | 122.0 | 84.0 | 140.0 | 40 | 89 |
Black | 77 | 126.2 | ± 13.1 | 125.0 | 98.0 | 188.0 | 95 | 172 |
Hispanic | 65 | 123.6 | ± 20.3 | 126.0 | -1.0 | 160.0 | 51 | 116 |
White | 672 | 123.2 | ± 19.0 | 124.0 | -1.0 | 188.0 | 430 | 1,102 |
Other | 3 | 139.0 | ± 25.7 | 130.0 | 119.0 | 168.0 | 6 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 833 | 15.1 | ± 42.9 | -2.0 | -2.0 | 178.0 | 683 | 1,516 |
Native American | 10 | 12.5 | ± 45.9 | -2.0 | -2.0 | 143.0 | 18 | 28 |
Asian | 47 | 13.2 | ± 40.4 | -2.0 | -2.0 | 136.0 | 42 | 89 |
Black | 73 | 12.9 | ± 43.4 | -2.0 | -2.0 | 178.0 | 99 | 172 |
Hispanic | 57 | 8.2 | ± 32.9 | -2.0 | -2.0 | 122.0 | 59 | 116 |
White | 643 | 16.2 | ± 43.9 | -2.0 | -2.0 | 162.0 | 459 | 1,102 |
Other | 3 | -2.0 | ± 0.0 | -2.0 | -2.0 | -2.0 | 6 | 9 |
Race/Ethnicity vs PM Systolic Blood Presure 1st Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 851 | 122.0 | ± 21.4 | 122.0 | -3.0 | 178.0 | 665 | 1,516 |
Native American | 13 | 115.1 | ± 36.1 | 120.0 | -1.0 | 140.0 | 15 | 28 |
Asian | 50 | 121.8 | ± 11.6 | 120.0 | 106.0 | 154.0 | 39 | 89 |
Black | 75 | 124.4 | ± 24.9 | 126.0 | -1.0 | 178.0 | 97 | 172 |
Hispanic | 61 | 118.7 | ± 24.8 | 122.0 | -1.0 | 160.0 | 55 | 116 |
White | 649 | 122.1 | ± 20.8 | 124.0 | -3.0 | 170.0 | 453 | 1,102 |
Other | 3 | 133.3 | ± 23.1 | 120.0 | 120.0 | 160.0 | 6 | 9 |